A. “Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer’s human brains,” by Hans-Ulrich Klein, Cristin McCabe, Elizabeta Gjoneska, Sarah E. Sullivan, Belinda J. Kaskow, Anna Tang, Robert V. Smith, Jishu Xu, Andreas R. Pfenning, Bradley E. Bernstein, Alexander Meissner, Julie A. Schneider, Sara Mostafavi, Li-Huei Tsai, Tracy L. Young-Pearse, David A. Bennett & Philip L. De Jage (Vol. 22, No. 1, January 2019, p. 37-46).
www.nature.com/articles/s41593-018-0291-1
B. “A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology,” by Hongjun Fu, Andrea Possenti, Rosie Freer, Yoshikazu Nakano, Nancy C. Hernandez Villegas, Maoping Tang, Paula V. M. Cauhy, Benjamin A. Lassus, Shuo Chen, Stephanie L. Fowler, Helen Y. Figueroa, Edward D. Huey, Gail V. W. Johnson, Michele Vendruscolo & Karen E. Duff (Vol. 22, No. 1, January 2019, p. 47-56).
www.nature.com/articles/s41593-018-0298-7
C. “Tau impairs neural circuits, dominating amyloid-{beta} effects, in Alzheimer models in vivo,” by Marc Aurel Busche, Susanne Wegmann, Simon Dujardin, Caitlin Commins, Julia Schiantarelli, Naomi Klickstein, Tarun V. Kamath, George A. Carlson, Israel Nelken & Bradley T. Hyman (Vol. 22, No. 1, January 2019, p. 57-64).
